Searched for
TAKEDA PHARMACEUTICALS USA
Lupin shares in focus after FDA nod for post-eye surgery drug Loteprednol Etabonate GelShares of Lupin are set to be in focus after it received US FDA approval for its generic Loteprednol Etabonate Ophthalmic Gel, granting it ...- Lupin launches generic chronic constipation treatment drug in USMumbai-based Lupin Ltd has introduced its generic Prucalopride tablets in the United States. This launch follows approval from the US healt...
- Lupin gets USFDA nod for generic chronic constipation treatment drugLupin Limited has received the United States Food and Drug Administration approval for its generic version of Prucalopride tablets. These t...
- Telangana secures over Rs 36,000 crore in life sciences investments, genome valley leads the wayTelangana's Genome Valley is attracting substantial investments in life sciences. Over Rs. 36,000 crore was invested in the past year. This...
- Dengue virus fever in USA: Over 9.7 million cases reported. Check symptoms, treatmentDengue fever is reported in the US as CDC has provided details about the Symptoms and treatment.
- Alembic Pharma gets USFDA nod for generic injection to treat hereditary angioedemaThe approval by the US Food & Drug Administration (USFDA) is for the Abbreviated New Drug Application (ANDA) for Icatibant injection of str...
- Indian pharmaceutical industry set for major transformation: Dilip ShanghviAt an annual meeting of the USA-India Chamber of Commerce in Boston, Shanghvi told a gathering of leading multinational drug makers about t...
- India becoming attractive for clinical trials, says pharma industry leadersOver the past decade, India has seen significant improvements in its clinical trial landscape, with a 15-18% growth in phase two and three ...
- Alembic Pharma gets tentative USFDA approval for depressive disorder drugCiting IQVIA data, the company said these Vortioxetine tablets have an estimated market size of USD 1,249 million for twelve months ending ...
- Top government officials, leaders from industry, academicians to take part in India-US Biopharma and Healthcare SummitNITI Aayog CEO Amitabh Kant, Pfizer CEO Dr Alberta Bourla, National Institutes of Health (NIH) Director Dr Francis Collins and Food and Dru...
- India scaling up production of active pharmaceutical ingredients: Amitabh KantSpeaking at the 14th Annual BioPharma and Healthcare Summit, the NITI Aayog CEO said India is now gearing up for innovation in its pharmace...
- Pharma sector needs global collaboration: Industry leaders, government officialsAhead of the 14th edition of the annual BioPharma and Healthcare Summit, that bring stakeholders from India and the United States on one pl...
- Granules India rises 3% on USFDA nod to insomnia drugThe company now has a total of 29 ANDA approvals from USFDA (27 final approvals and 2 tentative approvals), Granules India said.
- Alembic Pharma gets USFDA nod for Febuxostat tabletsShares of Alembic Pharmaceuticals were trading 3.86 per cent higher at Rs 523 apiece.
- India to unveil new drug policy: OfficialsA team of Indian officials led by G N Singh, Drug Controller General of India, said a set of new procedures to facilitate clinical trials a...
- Alembic Pharma gets tentative nod from USFDA for FebuxostatThe product is therapeutic equivalent to the reference listed drug Uloric tablets, 40 mg, 80 mg of Takeda Pharmaceuticals USA Inc, it added.
- Time for India to be innovator nation in bio-pharmaceuticals: Expert"India has a strong potential to become a hub for bio-pharma innovation and play a leading role in collaborative research for the same."
- Time for India to be innovator nation in bio-pharma: ExpertThis will have a huge economic impact creating high paying jobs, intellectual property and the real possibility for India to play a leading...
- Lupin gets USFDA approval for diabetes management drug"Lupin's Pioglitazone tablets is to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings," the co...
- Sun Pharmaceuticals files ANDAs for 4 products in Q1 FY14Sun Pharmaceutical Industries filed Abbreviated New Drug Applications for 4 products & received 9 approvals from USFDA in Q1 this fiscal.
Load More
